Yes, cholesterol plays a central role in clogging arteries, but the process is more complex than cholesterol simply piling up like grease in a pipe. Arterial clogging, known as atherosclerosis, involves LDL cholesterol particles entering damaged artery walls, triggering an inflammatory response that builds plaque over decades. This process begins far earlier than most people realize and involves your immune system as much as your diet.
How LDL Cholesterol Enters the Artery Wall
The process starts with damage to the inner lining of your arteries. Areas where blood flow is turbulent, such as bends and branch points in your arteries, experience lower shear stress. This weakens the protective inner layer of the artery wall, allowing LDL cholesterol particles to slip through and lodge in the tissue beneath.
Once trapped in the artery wall, LDL particles undergo chemical changes. They become oxidized, essentially turning rancid. This modified cholesterol is far more dangerous than the LDL circulating in your blood. The oxidized particles develop a strong negative charge that makes them extremely attractive to immune cells called macrophages, which rush to the site as part of your body’s inflammatory response.
Foam Cells: Where the Real Damage Happens
Macrophages try to clean up the oxidized LDL by swallowing it. But they absorb so much cholesterol that they become bloated, transforming into what scientists call foam cells. These engorged immune cells can’t leave the artery wall. Instead, they pile up, and as more arrive and gorge on oxidized cholesterol, they form the fatty core of a growing plaque.
This isn’t a passive buildup. Foam cell accumulation triggers a cascade of signals that recruit smooth muscle cells from deeper layers of the artery. These muscle cells migrate into the growing plaque and produce collagen and other structural proteins, forming a fibrous cap over the fatty core. The result is a layered structure: a soft, cholesterol-rich center covered by a tough outer shell, sitting inside your artery wall and narrowing the channel where blood flows.
This Starts in Childhood
Atherosclerosis is not a disease of old age. The earliest precursors, called fatty streaks, appear in childhood and are common by age 20 or 30. A nationwide autopsy study in Japan found fatty streaks in 29% of aortas in children younger than one year old, and in about 3% of coronary arteries in children aged one to nine. Even more striking, thickening of the artery’s inner layer has been detected in fetuses and infants, with gradual increases as children grow. Maternal high cholesterol during pregnancy appears to increase fatty streak formation in the developing baby.
These early changes don’t cause symptoms. Fatty streaks are flat, don’t block blood flow, and may even partially reverse. But they represent the soil in which full-blown plaques can grow over the following decades, especially if risk factors like high LDL cholesterol, smoking, high blood pressure, or diabetes persist.
Not All Cholesterol Contributes Equally
LDL is the primary driver of plaque formation, but not all LDL particles carry the same risk. Lipoprotein(a), often written as Lp(a), is a particularly sticky subtype of LDL that is more likely to cause blockages and blood clots. Your Lp(a) level is largely genetic, and a standard cholesterol test won’t measure it. Someone with a “healthy” total LDL number could still carry significant risk if a large share of their LDL is the Lp(a) type. A separate blood test can measure it.
HDL cholesterol, on the other hand, works in the opposite direction. HDL particles pull cholesterol out of foam cells in the artery wall and transport it back to the liver for disposal, a process called reverse cholesterol transport. This is the rate-limiting step in clearing cholesterol from plaques. Specialized transporters on foam cells hand off their cholesterol to HDL particles, which then carry it through the bloodstream to the liver, where it’s eventually excreted. This is why HDL is often called “good” cholesterol: it actively works to undo the damage LDL causes.
What Makes a Plaque Dangerous
A common misconception is that the biggest plaques cause heart attacks. In reality, the most dangerous plaques are often the ones you’d least expect. What matters most is the structure of the plaque, not its size.
Every mature plaque has two key components: a soft, fatty core and a fibrous cap holding it together. Plaques with thick, stable caps can narrow an artery significantly without ever rupturing. They may cause chest pain during exertion, but they rarely trigger sudden heart attacks. The real danger comes from plaques with thin caps and large fatty cores. When the cap becomes too weak to withstand the force of pulsating blood flow, it breaks open. Coronary plaques rarely rupture when the cap is thicker than 65 micrometers, roughly the width of a human hair.
When a thin-capped plaque does rupture, the fatty contents spill into the bloodstream. Your body treats this like an injury and forms a blood clot at the rupture site. That clot can partially or completely block the artery within minutes, cutting off blood supply to the heart muscle. This is a heart attack.
Measuring How Clogged Your Arteries Are
A standard cholesterol blood test tells you how much cholesterol is circulating in your blood, but it doesn’t reveal whether plaque has already formed. A coronary artery calcium (CAC) scan can. This quick, low-radiation CT scan detects calcified plaque in the heart’s arteries and assigns a score:
- CAC score of 0: very low risk, no detectable calcified plaque
- CAC score of 1 to 99: mildly increased risk
- CAC score of 100 to 299: moderately increased risk
- CAC score of 300 or higher: moderate to severely increased risk
A zero score is reassuring but not a lifetime guarantee, especially if your LDL remains elevated. Calcified plaque also represents older, more stable deposits. Newer, softer plaques that haven’t calcified yet won’t show up on this scan, which is why it’s used alongside blood tests and other risk assessments rather than as a standalone tool.
Can Existing Plaque Be Reversed?
For decades, the assumption was that arterial plaque could only be slowed, not shrunk. That’s changed. A large meta-analysis of clinical trials found that aggressive cholesterol-lowering therapy reduced plaque volume by a meaningful degree. Across studies, the overall reduction in plaque burden was about 1.1%, with some treatment combinations achieving reductions of up to 4%. Lipid-lowering treatments also increased fibrous cap thickness by an average of 26 micrometers, making existing plaques more stable and less likely to rupture.
The greatest regression occurred when LDL was driven very low. Clinical data show progressively better outcomes as LDL drops below 70 mg/dL, and secondary analyses of major trials found continued benefit even below 50 mg/dL. Current guidelines from the American Heart Association and American College of Cardiology recommend aggressive LDL lowering for people who have already had a cardiac event, with targets below 70 mg/dL and consideration of further reduction below 55 mg/dL in the highest-risk patients.
For people without existing heart disease, the practical takeaway is that lowering LDL earlier in life reduces the cumulative exposure your arteries face. Because plaque formation begins in childhood and progresses silently for decades, the total amount of LDL your artery walls absorb over a lifetime matters more than any single cholesterol reading. Keeping LDL low over many years gives HDL a better chance of clearing cholesterol faster than it accumulates, tipping the balance away from plaque growth and toward stability or even regression.